对精神病学渠道的分析。

Psychiatry (Edgmont (Pa. : Township)) Pub Date : 2010-09-01

Jeffrey Ventimiglia, Amir H Kalali

{"title":"对精神病学渠道的分析。","authors":"Jeffrey Ventimiglia, Amir H Kalali","doi":"","DOIUrl":null,"url":null,"abstract":"In this article, we explore the current state of the psychiatry drug development pipeline. Analysis suggests that overall, the psychiatry pipeline is heavily skewed toward a few major indications and tends to have more programs in early development (Phase I and II) than later stages (Phase III). A review of development sponsors shows a fairly even split of programs between Top 50 Pharmaceutical companies and small to mid-sized biopharmaceutical companies.","PeriodicalId":20822,"journal":{"name":"Psychiatry (Edgmont (Pa. : Township))","volume":"7 9","pages":"14-5"},"PeriodicalIF":0.0000,"publicationDate":"2010-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952641/pdf/PE_7_9_14.pdf","citationCount":"0","resultStr":"{\"title\":\"An analysis of the psychiatric pipeline.\",\"authors\":\"Jeffrey Ventimiglia, Amir H Kalali\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this article, we explore the current state of the psychiatry drug development pipeline. Analysis suggests that overall, the psychiatry pipeline is heavily skewed toward a few major indications and tends to have more programs in early development (Phase I and II) than later stages (Phase III). A review of development sponsors shows a fairly even split of programs between Top 50 Pharmaceutical companies and small to mid-sized biopharmaceutical companies.\",\"PeriodicalId\":20822,\"journal\":{\"name\":\"Psychiatry (Edgmont (Pa. : Township))\",\"volume\":\"7 9\",\"pages\":\"14-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952641/pdf/PE_7_9_14.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychiatry (Edgmont (Pa. : Township))\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry (Edgmont (Pa. : Township))","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

在这篇文章中，我们探讨了精神病学药物开发管道的现状。分析表明，总体而言，精神病学产品线严重倾向于少数主要适应症，并且往往有更多的项目处于早期开发阶段(I和II期)，而不是后期阶段(III期)。对开发赞助商的回顾显示，排名前50的制药公司和中小型生物制药公司之间的项目分配相当均匀。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

摘要图片

微信好友朋友圈 QQ好友复制链接

本刊更多论文

An analysis of the psychiatric pipeline.

In this article, we explore the current state of the psychiatry drug development pipeline. Analysis suggests that overall, the psychiatry pipeline is heavily skewed toward a few major indications and tends to have more programs in early development (Phase I and II) than later stages (Phase III). A review of development sponsors shows a fairly even split of programs between Top 50 Pharmaceutical companies and small to mid-sized biopharmaceutical companies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Psychiatry (Edgmont (Pa. : Township))

自引率

0.00%

发文量

期刊最新文献

Meow meow or miaow miaow: a new drug of concern. Medical disability and pain medication prescription among internal medicine outpatients. A review of new atypical antipsychotic launches in the United States. Psychiatric disorders: a global look at facts and figures. The blood brain barrier and the role of ratiometric molecular analysis in schizophrenia.